A Descriptive Study to Explore Certain Characteristics of Patients at Risk for Chronic Obstructive Pulmonary Disease (COPD) in a Primary Care Setting

November 18, 2010 updated by: AstraZeneca

A Descriptive Study to Explore Certain Characteristics of Patients at Risk for COPD in a Primary Care Setting

The purpose of this study is to explore if certain characteristics, easily detected within a regular primary care setting, may indicate that a patient at risk for COPD (45 ≤ age ≤ 80 years and a smoking history of ≥ 15 pack years) is prone to have a diagnosis of COPD according to Medical Products Agency guidelines.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

309

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Sweden
      • Alingsas, Sweden
        • Research Site
      • Arvidsjaur, Sweden
        • Research Site
      • Askim, Sweden
        • Research Site
      • Atvidaberg, Sweden
        • Research Site
      • Bromma, Sweden
        • Research Site
      • Eslov, Sweden
        • Research Site
      • Falun, Sweden
        • Research Site
      • Gagnef, Sweden
        • Research Site
      • Goteborg, Sweden
        • Research Site
      • Hagfors, Sweden
        • Research Site
      • Helsingborg, Sweden
        • Research Site
      • Hisings Karra, Sweden
        • Research Site
      • Hollviken, Sweden
        • Research Site
      • Jarpen, Sweden
        • Research Site
      • Karlshamn, Sweden
        • Research Site
      • Karlskrona, Sweden
        • Research Site
      • Kil, Sweden
        • Research Site
      • Limhamn, Sweden
        • Research Site
      • Linkoping, Sweden
        • Research Site
      • Lulea, Sweden
        • Research Site
      • Stockholm, Sweden
        • Research Site
      • Timra, Sweden
        • Research Site
      • Varnamo, Sweden
        • Research Site

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Primary care clinic

Description

Inclusion Criteria:

  • Patients with a history of smoking one pack of cigarettes per day for 15 years or more

Exclusion Criteria:

  • Known Chronic Obstructive Pulmonary Disease
  • Known severe cardiovascular disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Cohorts and Interventions

Group / Cohort
No treatment
Patients with a smoking history of 15 pack years or more.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
The patients will test their lung function with a COPD-6 screener for COPD and compare with regular spirometry. Medical records will be checked for health care contacts with respiratory diagnosis during the last 24 months prior to the study visit.
Time Frame: There will only be one visit in the study
There will only be one visit in the study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

AstraZeneca

Investigators

  • Principal Investigator: Björn Tilling, Åtvidabergs vårdcentral
  • Study Director: Georgios Stratelis, AstraZeneca

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2009

Primary Completion (Actual)

March 1, 2010

Study Completion (Actual)

March 1, 2010

Study Registration Dates

First Submitted

November 13, 2009

First Submitted That Met QC Criteria

November 13, 2009

First Posted (Estimate)

November 16, 2009

Study Record Updates

Last Update Posted (Estimate)

November 19, 2010

Last Update Submitted That Met QC Criteria

November 18, 2010

Last Verified

November 1, 2010

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NIS-RSE-DUM-2008/1

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe